CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Growing incidences of cardiac disorders and increasing geriatric population
3.4.1.2. Increasing patient awareness
3.4.1.3. Presence of high unmet medical needs

3.4.2. Restraints

3.4.2.1. Risks and complications associated with guidewires
3.4.2.2. Preference for drugs over treatment devices

3.4.3. Opportunities

3.4.3.1. Lucrative opportunities in emerging economies
3.4.3.2. Use of nitinol in vascular guidewires

3.4.4. Impact analysis

3.5. CLINICAL TRIALS

CHAPTER 4 VASCULAR GUIDEWIRES MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Key market tends
4.1.2. Key growth factors & opportunities
4.1.3. Market size & forecast
4.1.4. Coronary guidewires
4.1.5. Market size & forecast
4.1.6. Peripheral guidewires
4.1.7. Market size & forecast

CHAPTER 5 VASCULAR GUIDEWIRES MARKET, BY COATING TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. COATED

5.2.1. Hydrophilic Coatings
5.2.2. Hydrophobic coatings
5.2.3. Market size and forecast

5.3. NON-COATED

5.3.1. Market size and forecast

CHAPTER 6 VASCULAR GUIDEWIRES MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. AMBULATORY SURGICAL CENTERS (ASCS)

6.3.1. Market size and forecast

CHAPTER 7 GLOBAL VASCULAR GUIDEWIRES MARKET, BY REGION

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast
7.2.4. U.S.
7.2.5. Canada
7.2.6. Mexico

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast
7.3.4. Germany
7.3.5. France
7.3.6. UK
7.3.7. Italy
7.3.8. Spain
7.3.9. Rest of Europe

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast
7.4.4. Japan
7.4.5. China
7.4.6. India
7.4.7. South Korea
7.4.8. Australia
7.4.9. Rest of Asia-Pacific

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast
7.5.4. Brazil
7.5.5. South Africa
7.5.6. Saudi Arabia
7.5.7. Rest of LAMEA

CHAPTER 8 COMPANY PROFILES

8.1 ABBOTT LABORATORIES

8.1.1 Company Overview
8.1.2 Company Snapshot
8.1.3 Operating Business Segments
8.1.4 Business Performance
8.1.5 Key Strategic Moves & Developments

8.2 B. BRAUN MELSUNGEN AG

8.2.1 Company Overview
8.2.2 Company Snapshot
8.2.3 Operating Business Segments
8.2.4 Business Performance
8.2.5 Key Strategic Moves & Developments

8.3 BOSTON SCIENTIFIC CORPORATION

8.3.1 Company Overview
8.3.2 Company Snapshot
8.3.3 Operating Business Segments
8.3.4 Business Performance
8.3.5 Key Strategic Moves & Developments

8.4 C. R. BARD, INC.

8.4.1 Company Overview
8.4.2 Company Snapshot
8.4.3 Operating Business Segments
8.4.4 Business Performance
8.4.5 Key Strategic Moves & Developments

8.5 CARDINAL HEALTH, INC.

8.5.1 Company Overview
8.5.2 Company Snapshot
8.5.3 Operating Business Segments
8.5.4 Business Performance
8.5.5 Key Strategic Moves & Developments

8.6 COOK MEDICAL, INC.

8.6.1 Company Overview
8.6.2 Company Snapshot
8.6.3 Operating Business Segments
8.6.4 Key Strategic Moves & Developments

8.7 MEDTRONIC PLC

8.7.1 Company Overview
8.7.2 Company Snapshot
8.7.3 Operating Business Segments
8.7.4 Business Performance
8.7.5 Key Strategic Moves & Developments

8.8 BIOTRONIK SE & CO. KG

8.8.1 Company Overview
8.8.2 Company Snapshot
8.8.3 Operating Business Segments
8.8.5 Key Strategic Moves & Developments

8.9 TERUMO CORPORATION

8.9.1 Company Overview
8.9.2 Company Snapshot
8.9.3 Operating Business Segments
8.9.4 Business Performance
8.9.5 Key Strategic Moves & Developments

8.10 THE SPECTRANETICS CORPORATION

8.10.1 Company Overview
8.10.2 Company Snapshot
8.10.3 Operating Business Segments
8.10.4 Business Performance
8.10.5 Key Strategic Moves & Developments